Ishares Nasdaq Biotechno... Stock Quote 0JGB - Stock Price, News, Charts, Message Board, Trades

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
UK
LSE
Ishares Nasdaq Biotechnology (0JGB) Quote

Ishares Nasdaq Biotechnology (0JGB)

106.38

0.00

(0.00%)

Closed April 16 11:30AM

Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Current Price

106.38

Bid

0.00

Ask

0.00

Volume

778

0.00 Day's Range 0.00

106.38 52 Week Range 106.38

Market Cap

Previous Close

106.38

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

1,740

Shares Outstanding

62,100,000

Dividend Yield

-

PE Ratio

-85.41

Earnings Per Share (EPS)

-1.49

Revenue

58.15M

Net Profit

-92.78M

Sector

Mgmt Invt Offices, Open-end

Industry

Mgmt Invt Offices, Open-end

Website

www.ishares.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Ishares Nasdaq Biotechnology is listed in the Mgmt Invt Offices, Open-end sector of the London Stock Exchange with ticker 0JGB. The last closing price for Ishares Nasdaq Biotechno... was $106.38. Over the last year, Ishares Nasdaq Biotechno... shares have traded in a share price range of $ 106.38 to $ 106.38.

Ishares Nasdaq Biotechno... currently has 62,100,000 shares outstanding. The market capitalization of Ishares Nasdaq Biotechno... is $7.92 billion. Ishares Nasdaq Biotechno... has a price to earnings ratio (PE ratio) of -85.41.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	106.38	106.38	106.38	1018	106.38	DE
4	0	0	106.38	106.38	106.38	539	106.38	DE
12	0	0	106.38	106.38	106.38	1740	106.38	DE
26	0	0	106.38	106.38	106.38	1562	106.38	DE
52	0	0	106.38	106.38	106.38	1108	106.38	DE
156	0	0	106.38	106.38	106.38	1264	106.38	DE
260	0	0	106.38	106.38	106.38	1354	106.38	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WISAWiSA Technologies Inc	$ 6.58 (276.00%)	153.37M
PALIPalisade Bio Inc	$ 6.6099 (58.89%)	26.5M
JAGXJaguar Health Inc	$ 0.1838 (54.71%)	514.74M
SXTCChina SXT Pharmaceuticals Inc	$ 1.73 (47.86%)	30.35M
DYNTDynatronics Corp	$ 0.5158 (39.25%)	19.78M
PACBPacific Biosciences of California Inc	$ 1.585 (-44.09%)	35.51M
RVYLRYVYL Inc	$ 1.41 (-31.59%)	792.55k
NXLNexalin Technologies Inc	$ 1.425 (-28.03%)	597.47k
SYTASiyata Mobile Inc	$ 2.45 (-26.20%)	39.36k
KAVLKaival Brands Innovations Group Inc	$ 4.65 (-26.19%)	1.39M
JAGXJaguar Health Inc	$ 0.1838 (54.71%)	464.74M
WISAWiSA Technologies Inc	$ 6.58 (276.00%)	142.28M
SQQQProShares UltraPro Short QQQ	$ 11.385 (-0.48%)	87.84M
NKLANikola Corporation	$ 0.6762 (3.46%)	55.32M
TSLATesla Inc	$ 157.23 (-2.63%)	51.65M

Penny_Layne

Penny_Layne 5 minutes ago

They are the catalyst for all this...why would they care?

Monksdream

Monksdream 5 minutes ago

RIOT new 52 lo
https://investorshub.advfn.com/uimage/uploads/2024/4/16/nhrliIMG_7435.gif

otcsource

otcsource 5 minutes ago

KEGS SHAREHOLDERS are now THREATENING POSTERS on this board!! All I HAVE DONE IS STATED FACTS ABOUT WHAT IS OCCURRING WITH THE COMPANY KEGS!! AN RS AND HOW THE PRS HAVE NOT INCREASED COMMON SHAREHOLDERS VALUE!! I was told WHAT GOES AROUND COMES AROUND! I SHOULD NOT BE THREATENED BY SIMPLY STAT

Hi_Lo

Hi_Lo 5 minutes ago

The more zero shareholding bashers show up and intensify their rant....the more likely there is a pop coming
They show up with verifiable documentation to back up what they say - unlike you and the rest of the pumpers that can't prove any documentation for their rosy predictions.

Investor2014

Investor2014 5 minutes ago

If it wanted to, the Flying Spaghetti Monster could get a lot higher I'm sure.

rosemountbomber

rosemountbomber 5 minutes ago

Well sure as to what you say. However, you also say: "...future sales and marketing campaigns". That of course is the major reason for the lack of growth, the stopping of all marketing. And, that was because of the entrance of Generics. Until you can shake the Generics not much can be done.

johnny smartask

johnny smartask 5 minutes ago

May be why Nevada has gone in to Default?

varok

varok 5 minutes ago

Big buy slap 140m at .0004 and 100m on .0005 all buys today.

newmedman

newmedman 5 minutes ago

[yt]l0q7MLPo-u8[/yt]

slipihiv

slipihiv 5 minutes ago

My remaining Shares are up for grab,

Lone Clone

Lone Clone 5 minutes ago

IMPACT Silver Announces Full Year 2023 Results

Revenue Increased 27% to $20.7 Million

https://www.newsfilecorp.com/release/205671

April 16, 2024 11:28 AM EDT | Source: IMPACT Silver Corp.

Vancouver, British Columbia--(Newsfile Corp. - Ap

Mojocash

Mojocash 5 minutes ago

Slow n steady! Looks good to me

DarkPool

DarkPool 5 minutes ago

East’s gonna be controlling golds price shortly. They really like silver. Cheapest hard asset on the planet. Not much longer.

Invest-in-America

Invest-in-America 5 minutes ago

JAGX: Indeed!! (And, it's got too many shares out there; but, this could run in the Post-M today, & maybe tomorrow --- heck, just do an RS , like @WISA did, & send JAGX up to Jupiter too!!!)

FEARANDGREED

FEARANDGREED 6 minutes ago

I have not seen it mentioned here on the board, but another "Nice to see" is that the Nevada SOS filings are in order as of last month. If this had been mentioned earlier forgive me... Been extremely preoccupied with the car biz/building/wrenching these days. Anyway, good to see none the less.

Arti3boy

Arti3boy 6 minutes ago

Hold on tight men and ladies, the bash crew will be coming in talking about JT, even though he has no say anymore. The new team is crushing it and the next set of financials will be way better than this last round. Get your popcorn, you won’t want to miss the boat on this one.

bigstocksnbonds

bigstocksnbonds 6 minutes ago

Great job really great!!!!!

lucky, mydog

lucky, mydog 6 minutes ago

https://twitter.com/i/status/1778410113851871254

KMC-1

KMC-1 6 minutes ago

Over the long term I believe this company will do well, and I do agree the current administration is a huge part of the problem!

dcaf7

dcaf7 7 minutes ago

From today's presentation.
We don’t need to demonstrate activity on any single non-classical mutation to get a broad label. We need to cover a few mutations across certain subcategories of no-classical mutations shown in AACR presentation. These subcategories include L858R+non-classical, cla

J1989

J1989 7 minutes ago

Yea sorry there is a lot of non sense on here don’t have time to scroll through it all …. But let’s hope something happens this year … longs been getting destroyed

smoki

smoki 7 minutes ago

I like the re-branding! New beginnings Great move Cannabix!!

Banjo50

Banjo50 7 minutes ago

I think it should be five cents. Once it reaches five cents I will be a big time buyer. I will buy 1,000 shares maybe even 2,000.

condor1

condor1 7 minutes ago

Benny, why isn't "the mother lode" in production, you know , Bonanza?

Ishares Nasdaq Biotechno...

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions